日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Radiation Therapy for the Treatment of Sialocele in Dogs

放射疗法治疗犬唾液囊肿的疗效

Poirier, V J; Mayer-Stankeová, S; Buchholz, J; Vail, D M; Kaser Hotz, B

c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

c-Kit突变和定位状态作为犬肥大细胞瘤患者接受泼尼松和托西拉尼或长春碱治疗的疗效预测因子

Weishaar, K M; Ehrhart, E J; Avery, A C; Charles, J B; Elmslie, R E; Vail, D M; London, C A; Clifford, C A; Eickhoff, J C; Thamm, D H

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

雷巴福沙定/阿霉素交替用药:在初治犬多中心淋巴瘤中的疗效和耐受性

Thamm, D H; Vail, D M; Post, G S; Fan, T M; Phillips, B S; Axiak-Bechtel, S; Elmslie, R S; Klein, M K; Ruslander, D A

A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs

紫杉醇及其新型制剂(包括适用于犬类的制剂)综述

Khanna, C; Rosenberg, M; Vail, D M

Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.

脉冲式给药磷酸托西拉尼联合洛莫司汀治疗犬类不可切除的肥大细胞瘤

Burton J H, Venable R O, Vail D M, Williams L E, Clifford C A, Axiak-Bechtel S M, Avery A C, Thamm D H

Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma

VDC-1101治疗犬皮肤T细胞淋巴瘤的II期临床试验

Morges, M A; Burton, J H; Saba, C F; Vail, D M; Burgess, K E; Thamm, D H

A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs

一项随机试验旨在研究水溶性胶束紫杉醇(Paccal Vet)治疗犬类不可切除的2级或3级肥大细胞瘤的疗效和安全性。

Vail, D M; von Euler, H; Rusk, A W; Barber, L; Clifford, C; Elmslie, R; Fulton, L; Hirschberger, J; Klein, M; London, C; Martano, M; McNiel, E A; Morris, J S; Northrup, N; Phillips, B; Polton, G; Post, G; Rosenberg, M; Ruslander, D; Sahora, A; Siegel, S; Thamm, D; Westberg, S; Winter, J; Khanna, C

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study

长春碱和托西拉尼磷酸盐(Palladia®)联合用药在犬中的安全性评价:一项 I 期剂量探索研究

Robat, C; London, C; Bunting, L; McCartan, L; Stingle, N; Selting, K; Kurzman, I; Vail, D M

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma

开发表达异种gp100的同种异体全细胞肿瘤疫苗,并将其应用于犬恶性黑色素瘤患者的II期临床试验

Alexander, A N; Huelsmeyer, M K; Mitzey, Ann; Dubielzig, R R; Kurzman, I D; Macewen, E G; Vail, D M